SCHEMBL23553271

SCHEMBL23553271

CCNC(=O)C1CCN(C(=O)CNC(C)C)CC1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ KDM5A P29375 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ GAA P10253 2/20 0.43
▸ DPP4 P27487 1/20 0.43
▸ PTPN1 P18031 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ BCHE P06276 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25961547 0.86 GAA (0.54) HSD17B10SMN1; SMN2MEN1KMT2AGAA
SCHEMBL23553767 0.85 KMT2A (0.60) HSD17B10SMN1; SMN2MEN1KMT2AGAA
SCHEMBL20939066 0.82 HSD17B10 (0.46) HSD17B10SMN1; SMN2MEN1KMT2AGAA
SCHEMBL20939158 0.80 HSD17B10 (0.44) HSD17B10SMN1; SMN2MEN1KMT2ACYP3A4
SCHEMBL20857568 0.80 DPP4 (0.46) HSD17B10SMN1; SMN2MEN1KMT2AGAA
SCHEMBL23553276 0.80 DPP4 (0.48) MEN1KMT2ADPP4ALDH1A1TSHR
SCHEMBL20468901 0.78 DPP4 (0.43) HSD17B10SMN1; SMN2MEN1KMT2AGAA
SCHEMBL3272489 0.76 CYP3A4 (0.47) HSD17B10KMT2AKDM5ACYP3A4RAB9A
SCHEMBL2645027 0.75 DPP4 (0.47) SMN1; SMN2MEN1KMT2ARAB9AGAA
SCHEMBL30920935 0.75 DPP4 (0.47) SMN1; SMN2MEN1KMT2ARAB9ADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127586-A1 PROTEIN TYROSINE PHOSPHATASE DEGRADERS AND METHODS OF USE THEREOF CALICO LIFE SCIENCES LLC (US) 2021-06-24 — — WO disclosed
Send feedback